Kindly MD Inc (NAKA) - Price-to-Projected Revenue Ratio

The forward EV/Revenue ratio illustrates the business valuation trend, where 2.50 represents the latest metric reading. Kindly MD Inc (NAKA) integrates cannabis therapy into traditional healthcare to treat chronic pain. Operations rely on a network of clinics and secure cloud services. Back-office optimization is achieved through the testing of automation modules and the digitization of patient medical records.
Analytical breakdowns for Kindly MD Inc

The forward P/S ratio assesses the market value of Kindly MD Inc (NAKA) relative to its projected sales volume for the coming year. The trend in the forward P/S indicator reflects investor expectations regarding the pace of business scaling. This value is derived from the ratio of market capitalization to the expected cash flow from service sales. For Kindly MD Inc (NAKA), this metric indicates the efficiency of monetizing IT infrastructure outsourcing, which relieves clinics of the operational burden of managing technical support.